A prospective, open, single-center, single-arm phase II clinical study of PD-1 inhibitor combined with Furquintinib or Regominib in the treatment of third-line and later advanced colorectal cancer patients
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2698133
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Case series:PD-1 inhibitor combined with Furquintinib or Regominib
Primary outcome(s): Effect and safety
Study Design: Single arm
创建时间：
2021-01-15
